4//SEC Filing
Mahatme Sandesh 4
Accession 0001209191-20-042060
CIK 0000873303other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 8:00 PM ET
Size
16.8 KB
Accession
0001209191-20-042060
Insider Transaction Report
Form 4
Mahatme Sandesh
Senior Vice President, CFO
Transactions
- Exercise/Conversion
Stock option (right to buy)
2020-07-08$13.71/sh−218$2,989→ 0 totalExercise: $13.71From: 2017-02-28Exp: 2026-02-28→ Common Stock (218 underlying) - Exercise/Conversion
Common Stock
2020-07-08$13.71/sh+218$2,989→ 19,057 total - Exercise/Conversion
Stock option (right to buy)
2020-07-08$13.71/sh−2,385$32,698→ 0 totalExercise: $13.71From: 2017-02-28Exp: 2026-02-28→ Common Stock (2,385 underlying) - Gift
Common Stock
2020-05-11−20,425→ 16,454 total - Exercise/Conversion
Common Stock
2020-07-08$13.71/sh+2,385$32,698→ 18,839 total - Exercise/Conversion
Common Stock
2020-07-08$32.63/sh+1,203$39,254→ 20,260 total - Exercise/Conversion
Stock option (right to buy)
2020-07-08$32.63/sh−1,203$39,254→ 0 totalExercise: $32.63From: 2018-03-10Exp: 2027-03-10→ Common Stock (1,203 underlying)
Holdings
- 12,012(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This transaction involved a gift of shares of common stock by the reporting person to family trusts.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001511034
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 8:00 PM ET
- Size
- 16.8 KB